Yesterday, the Adjudicating Authority of the Prevention of Money Laundering Act (PMLA) had approved two separate attachment orders valued at Rs 51 crore and Rs 71 crore of the agency paving way for their immediate seizure by Enforcement Directorate (ED).
"The company has full regards for law and the legal process and that it is in the process of appealing the decision before the Appellate Tribunal. The Company maintains that there has been no wrongdoing on its part...," Aurobindo Pharma said in a filing to the BSE.
ED had attached 96 acres of land situated at Kota Bhogapuram Village, in Andhra Pradesh belonging to APL Research Centre Ltd, a 100 per cent subsidiary of the company, along with a fixed deposit of Rs 3 crore, the total value of which is equivalent to the value Rs 12.90 crore, it added.
"The company has contested the matter before the Adjudicating Authority under the Prevention of Money Laundering Act, 2002. The Adjudicating Authority vide Order dated February 15, 2013 has confirmed the attachment," the company said.
This attachment order does not have any material implications on the current and future business operations of the company, it added.
The ED had last year issued attachment orders on plots worth Rs 71 crore owned by Dubai-based Emaar Properties, its joint venture Emaar MGF and others in connection with its probe into alleged irregularities in land transfer and sale of villas and apartments at Hyderabad.
The agency had also issued attachment orders on properties worth Rs 51 crore as it attached more than 13 acres of land of Janani Infrastructure Pvt Ltd and fixed deposits worth Rs 14.50 crore of Jagati Publication Ltd as "kickbacks allegedly received in lieu of granting favours" to private entities.
The attachment order, issued under stringent provisions of PMLA, was also against private companies which were "illegally benefited as a result of criminal activity" and illegal sanctions granted during the tenure of Y S Rajasekhara Reddy.
The other properties attached by the agency are 35 acres of land and fixed deposit of Rs 3 crore of Hetero Drugs Ltd.
Shares of Aurobindo Pharma today closed at Rs 179.90 apiece on the BSE, down 3.72 per cent from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
